S&P 5007,666.60▲0.5% Nasdaq26,217.83▲0.5% Dow53,061.95▲0.6% Russell 2K2,953.17▲1.1% 10-Yr4.80%+0bp VIX15.20−1.14 WTI$90.70▲0.5% Gold$4,431.70▲1.9% EUR/USD1.159▼0.1% BTC$78,261▼1.1% Nikkei66,215▼0.1%
At close · Thu, Sep 3, 2026
Daily Market Updates.

Global Markets

Home›Global Markets›Trade & Tariffs›Swiss pharma CEO warns U.S. tariff threat could raise…

Swiss pharma CEO warns U.S. tariff threat could raise generic drug prices

Sandoz CEO Richard Saynor said steep tariffs on imported generic drugs could force manufacturers to either raise prices or reduce supply.

Reported · Written up by our desk · Trade & Tariffs

CNBC Markets reports that Sandoz CEO Richard Saynor warned that steep U.S. tariffs on imported generic drugs could push up costs and disrupt availability.

Saynor said manufacturers may respond by raising prices or cutting supply, effectively shifting the burden to patients.

The warning centers on how tariff pressure could affect the economics of importing generic medicines into the U.S., according to CNBC Markets.

← Newer storyCharles Cohen revives office plans for a Dania Beach complex

More like this

Global MarketsTrump threatened to bar Bombardier from selling in the US
Global MarketsXi urges deeper China-UK ties in first call with PM Andy Burnham
Global MarketsSouth Korea sends fact-finding team to assess Strait of Hormuz conditions
Global MarketsPakistan confirms operation of Chinese HQ-17AE short-range air defense
Global MarketsAustralia proposes option to switch off algorithmic social feeds

Sources

CNBC Markets'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
CNBC World'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.